Table 3

Evaluation of yield of each test individually and combinations of tests

ApproachNumber of patients identified for chemoprophylaxis (%)Number of patients missed (would have been identified via other methods) (%)Sensitivity versus triple combination testing (%)
Single test
 Risk factor approach alone27 (19.7)39 (28.5)40.9 (29.0–53.7)
 T.Spot positive alone25 (18.2)41 (29.9)37.9 (26.2–50.7)
 TST positive alone31 (22.6)35 (25.5)47.0 (34.6–59.7)
Double test combinations
 Risk factor and/or T.Spot positive48 (35.0)18 (13.1)72.7 (60.4–83.0)
 Risk factor and/or TST positive53 (38.7)13 (9.5)80.3 (68.7–89.1)
 T.Spot positive and/or TST positive47 (34.3)19 (13.9)71.2 (58.7–81.7)
Triple test combination
 Risk factor and/or T.Spot positive and/or TST positive66 (48.2)
  • Data shown as n (% of total cohort 137) or sensitivity (95% CI).

  • TST, tuberculin skin test.